[REGN] QoQ Quarter Result on 30-Sep-2016 [#Q3]

Stock
[REGN] Regeneron Pharmaceuticals, Inc.
Announcement Date
04-Nov-2016
Financial Year
2016
Quarter
30-Sep-2016 [#Q3]
Profit Trend
QoQ- 34.95%
YoY- 25.86%
Quarter Report
REGN's Result
REGN's Financial Summary
View:
Show?
Quarter Result
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
Revenue 1,470,116 1,318,991 1,226,827 1,220,122 1,212,629 1,200,849 1,098,077 21.49%
PBT 525,850 432,289 341,527 365,881 292,256 330,151 227,289 75.01%
Tax 138,106 183,358 88,412 101,077 96,038 164,415 72,295 54.01%
NP 387,744 248,931 253,115 264,804 196,218 165,736 154,994 84.38%
Tax Rate -26.26% -42.42% -25.89% -27.63% -32.86% -49.80% -31.81% -
Total Cost 1,082,372 1,070,060 973,712 955,318 1,016,411 1,035,113 943,083 9.62%
Ratio Analysis
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
NP Margin 26.38 18.87 20.63 21.70 16.18 13.80 14.12 51.74%
Per Share
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
EPS 3.66 2.36 2.41 2.53 1.88 1.74 1.49 82.15%
EPS Diluted 3.34 2.16 2.19 2.27 1.69 1.59 1.34 83.93%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.